Literature DB >> 3888043

Altered methionine metabolism and transmethylation in cancer.

R M Hoffman.   

Abstract

Methionine metabolism and transmethylation are frequently altered in cancer cells. The alteration is often expressed as an inability of the cancer cells to grow when methionine is replaced by homocysteine in the culture medium, a condition that allows the growth of normal cells. This metabolic defect is termed methionine dependence. Methionine dependence may reflect an overall imbalance in transmethylation which results in the overmethylation of some substances and undermethylation of others within cancer cells. Many carcinogens affect various stages of methionine/transmethylation metabolism. The ultimate effect of the alteration of methionine/transmethylation metabolism may be the disruption of the regulation of genes involved in the oncogenic process. The known protective effect of methionine against cancer may be due to prevention of altered methionine/transmethylation metabolism or compensation of the altered metabolism.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3888043

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  16 in total

1.  Application of alpha-aminoisobutyric acid, L-methionine, thymidine and 2-fluoro-2-deoxy-D-glucose to monitor effects of chemotherapy in a human colon carcinoma cell line.

Authors:  H Schaider; U Haberkorn; M R Berger; F Oberdorfer; I Morr; G van Kaick
Journal:  Eur J Nucl Med       Date:  1996-01

Review 2.  Specificity of the suppression of metastatic phenotype by tyrosine and phenylalanine restriction.

Authors:  C A Elstad; G G Meadows; R M Abdallah
Journal:  Clin Exp Metastasis       Date:  1990 Sep-Oct       Impact factor: 5.150

3.  Homocysteine accumulates in supernatants of stimulated human peripheral blood mononuclear cells.

Authors:  K Schroecksnadel; B Frick; B Wirleitner; H Schennach; D Fuchs
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

Review 4.  11C-L-methionine positron emission tomography in the clinical management of cerebral gliomas.

Authors:  Tarun Singhal; Tanjore K Narayanan; Viney Jain; Jogeshwar Mukherjee; Joseph Mantil
Journal:  Mol Imaging Biol       Date:  2007-10-24       Impact factor: 3.488

5.  Regulation of glutathione metabolism in Ehrlich ascites tumour cells.

Authors:  J M Estrela; R Hernandez; P Terradez; M Asensi; I R Puertes; J Viña
Journal:  Biochem J       Date:  1992-08-15       Impact factor: 3.857

6.  Differential volatile signatures from skin, naevi and melanoma: a novel approach to detect a pathological process.

Authors:  Tatjana Abaffy; Robert Duncan; Daniel D Riemer; Olaf Tietje; George Elgart; Clara Milikowski; R Anthony DeFazio
Journal:  PLoS One       Date:  2010-11-04       Impact factor: 3.240

7.  MTHFR genotype and colorectal adenoma recurrence: data from a double-blind placebo-controlled clinical trial.

Authors:  A Joan Levine; Kristin Wallace; Shirley Tsang; Robert W Haile; Fred Saibil; Dennis Ahnen; Bernard F Cole; Elizabeth L Barry; David J Munroe; Iqbal U Ali; Per Ueland; John A Baron
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-09       Impact factor: 4.254

8.  Effects of interferon beta on transcobalamin II-receptor expression and antitumor activity of nitrosylcobalamin.

Authors:  Joseph A Bauer; Bei H Morrison; Ronald W Grane; Barbara S Jacobs; Sally Dabney; Ana M Gamero; Kevin A Carnevale; Daniel J Smith; Judith Drazba; Bellur Seetharam; Daniel J Lindner
Journal:  J Natl Cancer Inst       Date:  2002-07-03       Impact factor: 13.506

9.  Cure of murine Trypanosoma brucei rhodesiense infections with an S-adenosylmethionine decarboxylase inhibitor.

Authors:  C J Bacchi; H C Nathan; N Yarlett; B Goldberg; P P McCann; A J Bitonti; A Sjoerdsma
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

10.  Metal based imaging probes of DO3A-Act-Met for LAT1 mediated methionine specific tumors: synthesis and preclinical evaluation.

Authors:  K Ganesh Kadiyala; Anupama Datta; Jyoti Tanwar; Anupriya Adhikari; B S Hemanth Kumar; Krishna Chuttani; Meganathan Thirumal; Anil K Mishra
Journal:  Pharm Res       Date:  2014-09-10       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.